Xencor reported $67.45M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 13959M 949M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
Alnylam Pharmaceuticals ALNY:US $ 220.55M 42.99M
Amgen AMGN:US $ 6526M 625M
Arrowhead Research ARWR:US $ 45.89M 13.08M
AstraZeneca AZN:LN 8220M 900M
Biogen BIIB:US $ 2778.9M 3.9M
Bristol Myers Squibb BMY:US $ 11703M 630M
Cytokinetics CYTK:US $ 2.84M 3.7M
Epizyme EPZM:US $ 13.01M 5.38M
GlaxoSmithKline GSK:LN 8092M 674M
Johnson & Johnson JNJ:US $ 23338M 26M
Karyopharm Therapeutics KPTI:US $ 22.6M 659K
Macrogenics MGNX:US $ 30.76M 13.88M
Merk MRK:US $ 11402M 678M
Novartis NOVN:VX SF 13294M 600M
Pfizer PFE:US $ 18977M 4395M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Seattle Genetics SGEN:US $ 388.48M 56.5M
Xencor XNCR:US $ 67.45M 33.48M